OrganiGram (NASDAQ:OGI) had its price objective reduced by Canaccord Genuity from C$3.50 to C$3.00 in a research report released on Wednesday morning, The Fly reports. They currently have a hold rating on the stock.
Several other equities analysts have also issued reports on the stock. Zacks Investment Research upgraded shares of OrganiGram from a sell rating to a hold rating in a report on Thursday, November 4th. Alliance Global Partners lowered their target price on shares of OrganiGram from C$3.75 to C$3.00 and set a neutral rating for the company in a report on Tuesday. They noted that the move was a valuation call. Finally, CIBC lowered their target price on shares of OrganiGram from C$4.00 to C$3.50 and set a neutral rating for the company in a report on Thursday, September 23rd. Seven equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of Hold and an average price target of $4.04.
OrganiGram stock opened at $2.16 on Wednesday. The stock’s 50 day simple moving average is $2.29 and its two-hundred day simple moving average is $2.58. The stock has a market cap of $647.66 million, a price-to-earnings ratio of -4.24 and a beta of 0.18. OrganiGram has a fifty-two week low of $1.15 and a fifty-two week high of $6.45.
Recommended Story: Environmental, Social, and Governance (ESG) Investing
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.